Product Code: GVR-4-68040-551-8
Pet Therapeutic Diet Market Growth & Trends:
The global pet therapeutic diet market size is anticipated to reach USD 6.44 billion by 2030 and is projected to grow at a CAGR of 7.3% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is driven by rising pet ownership, increasing awareness of pet health and wellness, and a growing prevalence of chronic conditions like obesity, diabetes, and gastrointestinal disorders in pets. Veterinary recommendations and science-backed formulations are fueling demand for specialized diets customized to manage these issues. In addition, key trends shaping the market include the surge in premium and prescription-based pet foods, increased focus on palatability and digestibility, and strategic collaborations between pet food companies, veterinarians, and regulatory bodies to enhance pet care standards.
Furthermore, a growing collaboration between key industry players and government authorities drives the market growth. For instance, in February 2025, Hill's Pet Nutrition partnered with the Association for Pet Obesity Prevention (APOP) to tackle the growing issue of pet obesity, which affects nearly two-thirds of pets in the U.S. This collaboration focuses on improving communication between veterinarians and pet owners, supporting evidence-based weight management, and addressing bias in veterinary care. The initiative also includes research, educational tools, and campaigns like "End Pet Obesity" to promote healthier lifestyles for pets. These partnerships focus on promoting pet health through evidence-based nutrition, regulatory support, and public awareness initiatives. By aligning standards for pet food safety, clinical efficacy, and educational outreach, such collaborations accelerate innovation and expand access to specialized therapeutic diets, ultimately improving overall pet wellness and veterinary care outcomes.
Growing innovation in wet food technology and an increase in the launch of pet therapeutic diets are driving market growth. For instance, in March 2024, Harley's Corner launched India's first domestically produced wet puppy and therapeutic dog food, utilizing advanced processing and precision nutrition to address specific canine health conditions such as renal failure, food allergies, gastrointestinal issues, joint problems, and obesity. With condition-specific formulations and cutting-edge wet food technology, the brand aims to support veterinary professionals in delivering targeted, clinically effective dietary care. This innovation is expected to accelerate the market growth in India by increasing accessibility to specialized diets, promoting clinical nutrition awareness, and supporting veterinary professionals with locally formulated, targeted dietary solutions.
Pet Therapeutic Diet Market Report Highlights:
- The dry food segment accounted for the largest market revenue share in 2024 and is anticipated to grow at the fastest CAGR during the forecast period. This is due to its convenience, longer shelf life, cost-effectiveness, and ease of storage and feeding.
- Based on animal type, the dog segment accounted for the largest revenue share of the market in 2024, due to higher ownership and diet needs, while the cat segment is set to grow fastest owing to rising cat adoption and increasing awareness of feline-specific health issues.
- Based on indication, the obesity care segment accounted for the largest market revenue share in 2024, due to rising pet obesity cases, while the renal care segment is projected to grow at the fastest CAGR of 7.8% during the forecast period, driven by the increasing prevalence of chronic kidney issues in pets.
- Based on distribution channel, the veterinary hospitals and clinics segment accounted for the largest market revenue share in 2024, due to increased pet health awareness and the rising prevalence of chronic diseases requiring professional dietary interventions. The e-commerce segment is expected to grow at the fastest CAGR during the forecast period.
- North America dominated the market with the largest revenue share of 40% in 2024. The Asia Pacific region is estimated to grow at the fastest CAGR of 8.0% during the forecast period.
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.1.1. Regional Scope
- 1.1.2. Estimates and Forecast Timeline
- 1.2. Market Definitions
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased Database
- 1.4.2. GVR's Internal Database
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.6.1. Commodity flow analysis
- 1.6.2. Global Market: CAGR Calculation
- 1.7. Research Scope and Assumptions
- 1.7.1. List of Secondary Sources
- 1.7.2. List of Primary Sources
- 1.7.3. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
Chapter 3. Pet Therapeutic Diet Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Ancillary Market Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Rising pet expenditure
- 3.2.1.2. Manufacturer's shift toward pet preventive care
- 3.2.1.3. The aging population and the demand for customized pet diet
- 3.2.1.4. Innovation in pet therapeutic diets
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. High cost of product
- 3.2.2.2. Lack of Adequate Research
- 3.2.3. Market Opportunity Analysis
- 3.2.4. Market Challenge Analysis
- 3.3. Pet Therapeutic Diet Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Bargaining power of suppliers
- 3.3.1.2. Bargaining power of buyers
- 3.3.1.3. Threat of substitutes
- 3.3.1.4. Threat of new entrants
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political & Legal Landscape
- 3.3.2.2. Economic and Social Landscape
- 3.3.2.3. Technological landscape
- 3.3.3. Estimated Animal Population, by key species & key countries, 2024
- 3.3.4. Pet Demographics Analysis
- 3.3.5. Consumer Trend Analysi
- 3.3.6. COVID-19 Impact Analysis
Chapter 4. Pet Therapeutic Diet Market: Product Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Pet Therapeutic Diet Market: Product Movement Analysis & Market Share, 2024 & 2030
- 4.3. Wet Food
- 4.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 4.4. Dry Food
- 4.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 4.5. Others
- 4.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 5. Pet Therapeutic Diet Market: Animal Type Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Pet Therapeutic Diet Market: Animal Type Movement Analysis & Market Share, 2024 & 2030
- 5.3. Dogs
- 5.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 5.4. Cats
- 5.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 5.5. Others
- 5.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 6. Pet Therapeutic Diet Market: Indication Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Pet Therapeutic Diet Market: Indication Movement Analysis & Market Share, 2024 & 2030
- 6.3. Renal Care
- 6.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 6.4. Obesity Care
- 6.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 6.5. Diabetic Care
- 6.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 6.6. Dental Care
- 6.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 6.7. Gastrointestinal Care
- 6.7.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 6.8. Recovery Care
- 6.8.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 6.9. Joint Care
- 6.9.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 6.10. Oncology (Restorative) Care
- 6.10.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 6.11. Others (Hydrolyzed Care, Urolith Care, Thyroid Care, etc.)
- 6.11.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 7. Pet Therapeutic Diet Market: Distribution Channel Estimates & Trend Analysis
- 7.1. Segment Dashboard
- 7.2. Pet Therapeutic Diet Market: Distribution Channel Movement Analysis & Market Share, 2024 & 2030
- 7.3. E-commerce
- 7.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.4. Veterinary hospitals & clinics
- 7.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.5. Retail Pharmacies
- 7.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.6. Others
- 7.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 8. Pet Therapeutic Diet Market: Regional Estimates & Trend Analysis
- 8.1. Regional Outlook
- 8.2. Pet Therapeutic Diet Market: Regional Movement Analysis & Market Share, 2024 & 2030
- 8.3. North America
- 8.3.1. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.2. U.S.
- 8.3.2.1. Key Country Dynamics
- 8.3.2.2. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.3. Canada
- 8.3.3.1. Key Country Dynamics
- 8.3.3.2. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.4. Mexico
- 8.3.4.1. Key Country Dynamics
- 8.3.4.2. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4. Europe
- 8.4.1. Europe Pet Therapeutic Diet Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.2. UK
- 8.4.2.1. Key Country Dynamics
- 8.4.2.2. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.3. Germany
- 8.4.3.1. Key Country Dynamics
- 8.4.3.2. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.4. France
- 8.4.4.1. Key Country Dynamics
- 8.4.4.2. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.5. Italy
- 8.4.5.1. Key Country Dynamics
- 8.4.5.2. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.6. Spain
- 8.4.6.1. Key Country Dynamics
- 8.4.6.2. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.7. Sweden
- 8.4.7.1. Key Country Dynamics
- 8.4.7.2. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.8. Denmark
- 8.4.8.1. Key Country Dynamics
- 8.4.8.2. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.9. Norway
- 8.4.9.1. Key Country Dynamics
- 8.4.9.2. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5. Asia Pacific
- 8.5.1. Asia Pacific Pet Therapeutic Diet Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.2. Japan
- 8.5.2.1. Key Country Dynamics
- 8.5.2.2. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.3. China
- 8.5.3.1. Key Country Dynamics
- 8.5.3.2. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.4. India
- 8.5.4.1. Key Country Dynamics
- 8.5.4.2. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.5. South Korea
- 8.5.5.1. Key Country Dynamics
- 8.5.5.2. Supplements Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.6. Australia
- 8.5.6.1. Key Country Dynamics
- 8.5.6.2. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.7. Thailand
- 8.5.7.1. Key Country Dynamics
- 8.5.7.2. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6. Latin America
- 8.6.1. Latin America Pet Therapeutic Diet Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6.2. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6.3. Brazil
- 8.6.3.1. Key Country Dynamics
- 8.6.3.2. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6.4. Argentina
- 8.6.4.1. Key Country Dynamics
- 8.6.4.2. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.7. Middle East & Africa
- 8.7.1. Middle East & Africa Pet Therapeutic Diet Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.7.2. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.7.3. South Africa
- 8.7.3.1. Key Country Dynamics
- 8.7.3.2. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.7.4. Saudi Arabia
- 8.7.4.1. Key Country Dynamics
- 8.7.4.2. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.7.5. UAE
- 8.7.5.1. Key Country Dynamics
- 8.7.5.2. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.7.6. Kuwait
- 8.7.6.1. Key Country Dynamics
- 8.7.6.2. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 9. Competitive Landscape
- 9.1. Market Participant Categorization
- 9.2. Key Company Profiles
- 9.2.1. Colgate-Palmolive Company (Hill's Pet Nutrition Inc.)
- 9.2.1.1. Company Overview
- 9.2.1.2. Financial Performance
- 9.2.1.3. Product Benchmarking
- 9.2.1.4. Strategic Initiatives
- 9.2.2. Nestle
- 9.2.2.1. Company Overview
- 9.2.2.2. Financial Performance
- 9.2.2.3. Product Benchmarking
- 9.2.2.4. Strategic Initiatives
- 9.2.3. Mars Petcare (Royal Canin)
- 9.2.3.1. Company Overview
- 9.2.3.2. Financial Performance
- 9.2.3.3. Product Benchmarking
- 9.2.3.4. Strategic Initiatives
- 9.2.4. General Mills Inc. (Blue Buffalo Company, Ltd.)
- 9.2.4.1. Company Overview
- 9.2.4.2. Financial Performance
- 9.2.4.3. Product Benchmarking
- 9.2.4.4. Strategic Initiatives
- 9.2.5. Diamond Pet Foods, Inc.
- 9.2.5.1. Company Overview
- 9.2.5.2. Financial Performance
- 9.2.5.3. Product Benchmarking
- 9.2.5.4. Strategic Initiatives
- 9.2.6. Virbac
- 9.2.6.1. Company Overview
- 9.2.6.2. Financial Performance
- 9.2.6.3. Product Benchmarking
- 9.2.6.4. Strategic Initiatives
- 9.2.7. Veterinary Nutrition Group
- 9.2.7.1. Company Overview
- 9.2.7.2. Financial Performance
- 9.2.7.3. Product Benchmarking
- 9.2.7.4. Strategic Initiatives
- 9.2.8. Farmina Pet Foods
- 9.2.8.1. Company Overview
- 9.2.8.2. Financial Performance
- 9.2.8.3. Product Benchmarking
- 9.2.8.4. Strategic Initiatives
- 9.2.9. JustFoodForDogs
- 9.2.9.1. Company Overview
- 9.2.9.2. Financial Performance
- 9.2.9.3. Product Benchmarking
- 9.2.9.4. Strategic Initiatives
- 9.2.10. EmerAid, LLC
- 9.2.10.1. Company Overview
- 9.2.10.2. Financial Performance
- 9.2.10.3. Product Benchmarking
- 9.2.10.4. Strategic Initiatives
- 9.3. Heat Map Analysis/ Company Market Position Analysis
- 9.4. List of Other Key Market Players
Chapter 10. Key Takeaways